The only industry-led meeting on the techniques to advance the development and commercialization of dermatological medicines.
Following a successful launch in Europe in 2019, the 2nd Dermatology Drug Development Europe Summit returns to 2021 in a fully digital format. As we weren’t able to meet in 2020, the need to meet next year has increased. The only end-to-end industry meeting committed to collaboratively generating new dermatological therapeutics to market. This year’s summit delivers an unrivaled prospect to industry experts in the dermatology space to examine methods to tackle key challenges and review opportunities in developing and bringing to market pioneering dermatology medicines.
Join peers and leaders in this space for an exclusive three-day meeting of comprehensive discussion, sharing of latest advances and pioneering insights, and networking opportunities to address the ever-changing landscape of dermatology, this year’s event focuses not just on the big three: Acne, Psoriasis and Atopic Dermatitis (AD), but other severe conditions such as alopecia, pruritus, vitiligo, and rosacea; making this event the definitive meeting for drug developers to debate the preclinical, clinical and commercial challenges in creating innovative dermatological medicines.
Discover new preclinical modeling solutions, debate the optimal formulation strategy, define your clinical development plan, appreciate the regulatory considerations, and evaluate different commercialization routes. Hear from a faculty of expert leaders including BfArM, FDA, LEO Pharma, Galderma, and Almirall, who will be sharing their learning and latest case-studies.
The Virtual Conference takes place on 17-19 February 2021. To view the brochure, click here: https://ter.li/hznhuk